Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF593OS" (ZNF593 opposite strand) is annotated as a small putative transmembrane protein in humans, consisting of 63 amino acids[7]. It appears to be the gene product of the ZNF593OS gene, which is coded on the opposite DNA strand from the ZNF593 (Zinc finger protein 593) gene. Unlike ZNF593, a functionally established zinc finger protein involved in nucleic acid binding and transcription regulation[1][3][5], there is currently no published evidence for a clear molecular function, biological role, or therapeutic targeting of ZNF593OS. There are no known disease associations, interacting drugs, or biomarker indications. The entry is not recognized as a conventional therapeutic target (such as a receptor, enzyme, transporter, or transcription factor). Note on is_incorrect: The entry "ZNF593OS" (ZNF593 opposite strand) may be problematic or misleading: - There is confusion between "ZNF593" (a characterized zinc finger transcription factor[1][3][5]) and "ZNF593OS," which refers to a non-overlapping, putative transmembrane protein with little functional or biomedical characterization[7]. - Most literature and databases discuss "ZNF593" as the functionally relevant gene; "ZNF593OS" does not appear to be a validated molecular or therapeutic target. - If the intention was to retrieve information for ZNF593, the zinc finger transcription factor, please clarify. - As currently described, "ZNF593OS" is a poorly characterized gene product and not established as a drug target, receptor, or functional protein in human disease or signaling pathways[7]. In summary: At present, "ZNF593OS" is not an established molecular target. Most relevant structural and functional data applies to ZNF593, a distinct protein. If further information on "ZNF593" is desired, that can be provided.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein ZNF593OS (ZNF593OS).